Amoxicillin outperforms penicillin V in treating pediatric pneumonia, study finds

FHS
June 18, 2024
5:29 am

A recent study confirmed amoxicillin’s lower risk of treatment failure compared to penicillin V in treating pediatric pneumonia, with no difference in severe complications.

atai Life Sciences Announces Results from the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine) | Psychedelic Invest

atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, announced results from Perception Neuroscience’s Phase 1

August 10, 2023

STRATEC POSTS RESULTS FOR FIRST QUARTER OF 2024 – Biotech Investments

EQS-News: STRATEC SE / Key word(s): Quarter Results STRATEC POSTS RESULTS FOR FIRST QUARTER OF 2024 26.04.2024 / 06:55 CET/CEST The issuer is solely responsible

April 27, 2024

Osteoporosis market expected to reach $17.9bn across 7MM by 2033

The osteoporosis market is expected to grow at a compound annual growth rate of 5.4% from 2023 to 2032, reaching $17.9bn across the seven major

June 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.